Global Cancer
2018 Estimates:
18.1 Million Cancer Cases
And 9.6 Million deaths!
“Cancer is not a disease;
It’s Big Business!
(M. Javed Naseem)
With immense technological advancement and new inventions,
our society is slowly becoming addicted to the artificial comforts of life. In
reality, we are becoming sick both physically and morally. Corruption and
injustice are all over the world, in every sphere of life, and everybody is
looking for peace and happiness. Technological development has poisoned our
food-grains, crops, vegetables and fruits genetically and along with that also
the fertilizers. When these two sides attack and we get sick, we seek relief in
the third one, which is medicine. Unfortunately, the medication helps less with
the cure of our ailment but spreads the diseases, actually diseases, being the
side-effects. We are trapped in a death-trap by the Big Pharma.
First, it was AIDS; then heart-attack and now it is cancer
that’s taking people’s lives. The worst part is that before killing people,
this cancer business makes their lives miserable. The doctors try to prolong
this misery as much as possible to milk more money and the Big Pharma benefits
from it by selling more and more expensive drugs. The butcher doctors even
prescribe drugs that they know are not going to work in a particular situation
or stage of the disease, still they do prescribe them. It’s all about money.
Watch Out!
One-in-five men
and one-in-six women
worldwide will
develop cancer over the
course of their
lifetime! – IARC
Ever wonder how these ‘experts’ (actually Big Pharma)
predict the number of future patients and diseases? Easy! They manufacture
drugs and sell it. Every drug has negative side-effects – every drug, without
exception. They attack your liver, kidneys, lungs, heart and above all your
immune system – your defense wall. Millions of drug-doses make millions of new
patients of new diseases (caused by the side-effects) every year and then the
numbers expand – and so does the profits for the Big Pharma. All doctors work
for them, directly or indirectly, getting commissions, percentage or kickbacks.
Once you walk in their clinics, you cannot walk out 100% healthy – never!
Whistle-blowers have taken the risk and come forward to tell
people that cancer has become an industry – 3 trillion dollar business every
year – that offers big profits. It is not about curing the disease; it is about
prolonging it and making maximum profits. Drug companies (pharmaceuticals) are
making billions of dollars profits every year, even when the economy is in
crisis. What happens to the suffering humanity in the process is not their
problem; it’s yours. So, handle it the way you want.
Captain Dale Black was an airline pilot. His wife got cancer
and over the years he became a researcher. He talks from his personal
experience and research he did in this field. He says that cancer is not a
disease; it’s big business!
“Cancer is not a
disease; It’s Big Business!”
-- Capt. Dale Black
“Finally, there's hope for cancer patients. Cancer, all
forms of cancer, doesn't just fall from the sky. Generally speaking, we give
cancer to ourselves by the way we think, eat, drink and by how we deal with
stress. In other words, how we LIVE. Cancer is preventable. Cancer is
reversible. There is hope for cancer patients. Watch and learn.” (This
particular video is intended only for adults with cancer).
***************************************
Butchers of Big Pharma
slaughter people every day
in the name of cancer treatment
to make big money! Drugs spread
diseases and offer no cure!
“I worked in an
industry, the Pharmaceutical
Industry that do
nothing, but annihilate the
population of this world.
They kill more people
than wars we have in
the world, but long term.
They punish you and
then they kill you.”
– Dr. John R.
Virapen
***************************************
The IARC – world cancer research agency – issued a report
for 2018, with alarming facts and figures. Here are the excerpts:
Geneva, Switzerland, 12 September 2018
– New global cancer data suggests that the global cancer burden has risen
to 18.1 million cases and 9.6 million cancer deaths.
The International Agency for Research on Cancer (IARC)
estimate that one-in-five men and one-in-six women worldwide will develop
cancer over the course of their lifetime, and that one-in-eight men and
one-in-eleven women will die from their disease. A number of factors appear to be
driving this increase, particularly a growing and ageing global
population and an increase in exposure to cancer risk factors linked to
social and economic development. For rapidly-growing economies, the data
suggests a shift from poverty- or infection-related cancers to those
associated with lifestyles more typical in industrialized countries.
There are some indications that scaled-up prevention efforts
are starting to reduce cancer incidence rates, for example lower lung cancer
incidence in men in Northern Europe and North America,
or in cervical cancer across most regions except Sub-Saharan Africa compared to
2012 data.
However countries are facing an overall increase in
the absolute number of cancer cases. Asia
accounts for nearly half of the new cancer cases and more than half of cancer
deaths.
Estimated suggest that Asia and Africa have a higher proportion
of cancer deaths (7.3% and 57.3% respectively) compared with their incidence
(5.8% and 48.4% respectively). IARC suggests this trend is likely due to the
higher frequency of cancer types associated with poorer prognosis, along with
limited access to timely diagnosis and treatment. The 2018 data also suggests
that countries with high Human Development Index (HDI) have 2-3 times
higher cancer incidence than those with low or medium HDI.
Clear call for action
It is clear that cancer is an urgent global challenge and
Governments must take measures to scale up prevention, early detection and
diagnosis, treatment, and care services. The global cancer community has an
important role to play in holding Governments accountable to their commitments
and advocating for accelerated and evidence-based action nationally.
One of the key concerns raised by IARC is that lung
cancer is the leading cause of death globally and its prevalence is rising
amongst women, surpassing breast cancers in 28 countries.
Excerpts from a New York Times report:
Feeding the Cancer
Machine
By Shannon Brownlee
HAVE you ever wondered why hospitals offer free cancer
screening tests? You’ve heard the ads on radio, and seen them in newspapers,
urging you to come to your local hospital for a free Pap smear, mammogram or
prostate cancer blood test.
Hospitals would like you to think they are doing this out of
the goodness of their hearts, that free cancer screening is a public service
intended solely to improve your health. But there may be another motive at work
here: providing free screening brings in new cancer patients, and cancer
generates profits.
Has the profit motive gotten in the way of finding a cure
for cancer or better treatment? Could it be that at least some of the $100
billion we spend each year on detecting and treating this disease is used not
to improve the health of patients, but rather to prop up hospital finances?
Cancer makes money for hospitals in a couple of ways. First,
it’s a disease of aging, and that means the majority of people who get it are
covered by Medicare, which always pays its bills. Second, many treatments for
cancer patients are particularly profitable, especially compared to those for
other diseases.
Hospitals generally make money on surgery to remove cancer.
Then there are all the imaging tests, like CT scans and M.R.I.’s, which are
also well reimbursed by Medicare and other payers. The more cancer patients a
hospital can attract, the faster it can recoup capital investments in imaging
machines.
Another big source of profit is cancer drugs. Worldwide, we
spend about $35 billion a year on chemotherapy and other drugs related to
cancer treatment. Hospitals make money on drugs by purchasing wholesale and
charging insurers full price. Cancer doctors also purchase drugs wholesale,
making as much as two-thirds of their income on the “chemotherapy concession,”
in which they sell and administer chemotherapy drugs in their offices.
Hospitals and doctors need to make money, of course, but the
high profit margin in cancer has created a situation where providers have every
reason to screen more people and treat those who are diagnosed with cancer more
aggressively — and few incentives to hold back, even if that’s what the patient
might prefer. Recognizing this, Medicare reduced its reimbursements for
chemotherapy in 2005, but even with those changes, cancer remains an enormous
economic engine in our health care system.
Sure, aggressive treatment is reducing mortality and
improving the quality of life for some patients. Sometimes it even cures. But
for many others, the cancer machine offers only marginal benefits at best, and
providers push screening and aggressive treatment in part because they have
nothing else to give, but also because it’s profitable. How much of the money
we spend on unnecessary or futile cancer treatment might be put to better use
searching for real advances?
Chemotherapy warning as
hundreds die
from cancer-fighting
drugs
By Sarah Knapton, Science Editor, The Telegraph (pub. 30
August 2016)
Patients should be warned about the dangers of chemotherapy
after research showed that cancer drugs are killing up to 50 per cent of
patients in some hospitals.
For the first time researchers looked at the numbers of
cancer patients who died within 30 days of starting chemotherapy, which
indicates that the medication is the cause of death, rather than the cancer.
The study by Public Health England
and Cancer Research UK found
that across England
around 8.4 per cent of patients with lung cancer, and 2.4 per cent of breast
cancer patients died within a month.
But in some hospitals the figure was far higher. In Milton Keynes the death rate for lung cancer treatment
was 50.9 per cent, although it was based on a very small number of patients.
At Lancashire Teaching Hospitals the 30 day mortality rate
was 28 per cent for palliative chemotherapy for lung cancer, which is given
when a cure is not expected and treatment given to alleviate symptoms.
Deaths of lung cancer patients from chemotherapy were also
far higher than the national average in Blackpool, Coventry,
Derby, South Tyneside and Surrey and Sussex,
according to the research.
Similarly, around one in five people who underwent
palliative care for breast cancer at Cambridge University Hospitals died from
their treatment.
The study looked at more than 23,000 women with breast
cancer and nearly 10,000 men with 9634 non-small cell lung cancer who underwent
chemotherapy in 2014. Of those treated 1,383 died within 30 days.
Chemotherapy is toxic for the body because it does not
discriminate between healthy and cancerous cells.
The researchers also found that there were significant
differences in survival for older people and those in poorer health. They
advised doctors to be more careful in selecting patients for treatment where it
could do more harm than good.
Professor David Dodwell, Institute
of Oncology, St James Hospital, Leeds, UK,
says:
“I think it’s important to make patients aware that there
are potentially life threatening downsides to chemotherapy. And doctors should
be more careful about who they treat with chemotherapy.”
Professor David Cameron, Edinburgh Cancer Centre, Western General Hospital,
Edinburgh, Scotland, added: “The concern is
that some of the patients dying within 30 days of being given chemo probably
shouldn’t have been given the chemo. But, how many? There is no easy way to
answer that, but perhaps looking at those places/hospitals where the death rate
was higher might help.
The research was published in The Lancet Oncology.
The Cancer Industry
Expects 1.7 million New Cancer Cases in the US for 2019
Corporate healthcare policies are based on real world
figures and estimates based on actions taken from previous fiscal years, e.g.
mass vaccinations. It is estimated that more than 1.7 million new cancer cases
are expected to be diagnosed in 2019, according to the data published by the American
Cancer Society this year.
This estimate, according to the same report, does not
include carcinoma in situ (noninvasive cancer) of any site except urinary
bladder, nor does it include basal cell or squamous cell skin cancers because
these are not required to be reported to cancer registries. In short, there
will be more than they could feast upon as the days go by.
How many will die of
cancer this year?
About 606,880 Americans are expected to die of cancer in
2019, which translates to about 1,660 deaths per day.
Cancer is the second most common cause of death in the US,
exceeded only by heart disease. All of these figures can help in the
determination of pricing of medical goods and services, and the exact amount of
investments in the building of new hospitals and morgues across the different
states. The rest will be budgeted for public relations and medical incentives
for all professional medical practitioners who are devoutly
participating in the real world hunger games.
As of today, the top 6 pharmaceutical stocks that you can buy
shares from are the following:
Market Cap: $124.73 billion
Performance: 35.6% annual return
Market Cap: $196.84 billion
Performance: 34.5% annual return
Market Cap: $227.87 billion
Performance:18.7% annual return
Market Cap: $48.98 billion
Performance: 17.7% annual return
Market Cap: $375.67 billion
Performance: -7.3% annual return
Market Cap: $116.53 billion
Performance: -9.33% annual return
Eli Lilly is where Dr. John Rengen Virapen used to work for
the better part of his life. It was the birth of his own son that changed it
all.
“I worked in an industry, the Pharmaceutical Industry that
do nothing, but annihilate the population of this word. They kill more people
than wars we have in the world, but long term. They punish you and then they
kill you.” – Dr. John R. Virapen
Whether one dies or cured of cancer, both scenarios are
always unwelcomed. The primary objective is to prolong the agony, as much as
possible, which explains the contradicting prescriptions of hazardous chemo,
sodium bicarbonate, and a load of multi-vitamins.
According to a peer-reviewed study, a majority of patients
(51.3%) received conflicting medication information that had a direct negative
effect on medication adherence. Cancer takes about 10 years to develop from the
time of infection, whether induced or consequential. The 10-year lead-time is a
strong manifestation of the resiliency and competence of the autoimmune system
without any form of intervention.
If each of the estimated 1.7 million new cancer cases spends
$250,000 for cancer treatment, a whopping $425 billion can be generated in the US
alone. But this estimate is too conservative considering that in the year 2017
alone, the U.S.
health care spending grew by 3.9 percent, reaching $3.5 trillion or $10,739 per
person.
That is, of course, a combined figure of expenditures for
all types of health conditions from The National Health Expenditure Accounts
(NHEA).
Globally, the total health expenditures in 2015 alone is
pegged at $7.2 trillion. About half of that amount was spent by the Americans,
which makes them the most chemically and financially devastated population on
the planet.
All of the above numbers continue to feed the corrosive
system in spite of the growing number of independent companies promoting alternative
approaches to healthcare.
Imagine if, instead of poisoning ourselves with toxic
chemicals that have no useful purpose in our body, we spent the $7.2 trillion
on the implementation of better technologies, new infrastructures, housing and
new industries, we could have dotted this planet with beautiful, sustainable
cities and better societies, a long time ago.
***************
